Explore the detailed record of transactions filed by FOLETTA MARK G, Director. Officer active across 2 companies, notably DEXCOM INC. In total, 12 disclosures have been logged. Total volume traded: €522k. The latest transaction was disclosed on 19 May 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Mark G. Folette is a Director at Dexcom Inc and AMN Healthcare Services Inc. He plays a key role in corporate governance and strategic decision-making. His expertise is essential for guiding the companies' initiatives.